Celularity Stock Market Value
| CELU Stock | USD 2.01 0.84 29.47% |
| Symbol | Celularity |
Celularity Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Celularity. If investors know Celularity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Celularity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Earnings Share (104.78) | Revenue Per Share 2.099 | Quarterly Revenue Growth 3.122 | Return On Assets (0.15) |
The market value of Celularity is measured differently than its book value, which is the value of Celularity that is recorded on the company's balance sheet. Investors also form their own opinion of Celularity's value that differs from its market value or its book value, called intrinsic value, which is Celularity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Celularity's market value can be influenced by many factors that don't directly affect Celularity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Celularity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Celularity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Celularity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Celularity 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Celularity's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Celularity.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Celularity on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Celularity or generate 0.0% return on investment in Celularity over 30 days. Celularity is related to or competes with Immix Biopharma, ZyVersa Therapeutics, Hepion Pharmaceuticals, Cns Pharmaceuticals, and Sonnet Biotherapeutics. Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therap... More
Celularity Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Celularity's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Celularity upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 9.79 | |||
| Information Ratio | 0.0151 | |||
| Maximum Drawdown | 149.72 | |||
| Value At Risk | (14.68) | |||
| Potential Upside | 11.99 |
Celularity Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Celularity's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Celularity's standard deviation. In reality, there are many statistical measures that can use Celularity historical prices to predict the future Celularity's volatility.| Risk Adjusted Performance | 0.027 | |||
| Jensen Alpha | 0.2426 | |||
| Total Risk Alpha | (2.11) | |||
| Sortino Ratio | 0.0254 | |||
| Treynor Ratio | 0.3453 |
Celularity Backtested Returns
Celularity appears to be abnormally volatile, given 3 months investment horizon. Celularity secures Sharpe Ratio (or Efficiency) of 0.0209, which signifies that the company had a 0.0209% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Celularity, which you can use to evaluate the volatility of the firm. Please makes use of Celularity's Mean Deviation of 7.63, risk adjusted performance of 0.027, and Downside Deviation of 9.79 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Celularity holds a performance score of 1. The firm shows a Beta (market volatility) of 1.06, which signifies a somewhat significant risk relative to the market. Celularity returns are very sensitive to returns on the market. As the market goes up or down, Celularity is expected to follow. Please check Celularity's downside variance, and the relationship between the sortino ratio and accumulation distribution , to make a quick decision on whether Celularity's price patterns will revert.
Auto-correlation | -0.36 |
Poor reverse predictability
Celularity has poor reverse predictability. Overlapping area represents the amount of predictability between Celularity time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Celularity price movement. The serial correlation of -0.36 indicates that just about 36.0% of current Celularity price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.36 | |
| Spearman Rank Test | -0.22 | |
| Residual Average | 0.0 | |
| Price Variance | 0.18 |
Celularity lagged returns against current returns
Autocorrelation, which is Celularity stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Celularity's stock expected returns. We can calculate the autocorrelation of Celularity returns to help us make a trade decision. For example, suppose you find that Celularity has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Celularity regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Celularity stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Celularity stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Celularity stock over time.
Current vs Lagged Prices |
| Timeline |
Celularity Lagged Returns
When evaluating Celularity's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Celularity stock have on its future price. Celularity autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Celularity autocorrelation shows the relationship between Celularity stock current value and its past values and can show if there is a momentum factor associated with investing in Celularity.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.